These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3504546)

  • 1. Profiles of antibody-dependent enhancement of dengue virus type 2 infection.
    Morens DM; Halstead SB; Marchette NJ
    Microb Pathog; 1987 Oct; 3(4):231-7. PubMed ID: 3504546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies.
    Halstead SB; Venkateshan CN; Gentry MK; Larsen LK
    J Immunol; 1984 Mar; 132(3):1529-32. PubMed ID: 6607288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses.
    Morens DM; Venkateshan CN; Halstead SB
    J Gen Virol; 1987 Jan; 68 ( Pt 1)():91-8. PubMed ID: 2433388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated enhancement of dengue virus infection in mouse macrophage cell lines, Mk1 and Mm1.
    Hotta H; Wiharta AS; Hotta S
    Proc Soc Exp Biol Med; 1984 Mar; 175(3):320-7. PubMed ID: 6364153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants.
    Brandt WE; McCown JM; Gentry MK; Russell PK
    Infect Immun; 1982 Jun; 36(3):1036-41. PubMed ID: 6284641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodies.
    Morens DM; Halstead SB
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():2909-14. PubMed ID: 2273390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the distribution of antibody-dependent enhancement determinants on dengue 2 isolates using dengue 2-derived monoclonal antibodies.
    Morens DM; Larsen LK; Halstead SB
    J Med Virol; 1987 Jun; 22(2):163-7. PubMed ID: 2440986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.
    Frei JC; Wirchnianski AS; Govero J; Vergnolle O; Dowd KA; Pierson TC; Kielian M; Girvin ME; Diamond MS; Lai JR
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine.
    Guy B; Chanthavanich P; Gimenez S; Sirivichayakul C; Sabchareon A; Begue S; Yoksan S; Luxemburger C; Lang J
    Vaccine; 2004 Sep; 22(27-28):3563-74. PubMed ID: 15315835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein.
    Tang CT; Liao MY; Chiu CY; Shen WF; Chiu CY; Cheng PC; Chang GJ; Wu HC
    PLoS One; 2015; 10(8):e0136328. PubMed ID: 26309127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention.
    Goncalvez AP; Engle RE; St Claire M; Purcell RH; Lai CJ
    Proc Natl Acad Sci U S A; 2007 May; 104(22):9422-7. PubMed ID: 17517625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays.
    Yamanaka A; Suzuki R; Konishi E
    Vaccine; 2014 Jul; 32(34):4289-95. PubMed ID: 24950360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease severity-related antigenic differences in dengue 2 strains detected by dengue 4 monoclonal antibodies.
    Morens DM; Halstead SB
    J Med Virol; 1987 Jun; 22(2):169-74. PubMed ID: 2440987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement-independent dengue virus type 1 infection-enhancing antibody reduces complement-dependent and -independent neutralizing antibody activity.
    Yamanaka A; Konishi E
    Vaccine; 2016 Dec; 34(51):6449-6457. PubMed ID: 27866774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein.
    Budigi Y; Ong EZ; Robinson LN; Ong LC; Rowley KJ; Winnett A; Tan HC; Hobbie S; Shriver Z; Babcock GJ; Alonso S; Ooi EE
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006209. PubMed ID: 29425203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence.
    Henchal EA; Gentry MK; McCown JM; Brandt WE
    Am J Trop Med Hyg; 1982 Jul; 31(4):830-6. PubMed ID: 6285749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-mediated enhancement of infection by dengue virus of the P815 murine mastocytoma cell line.
    Legrand LF; Hotta H; Hotta S; Homma M
    Biken J; 1986 Jun; 29(2):51-5. PubMed ID: 3101662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies.
    Henchal EA; McCown JM; Burke DS; Seguin MC; Brandt WE
    Am J Trop Med Hyg; 1985 Jan; 34(1):162-9. PubMed ID: 2578750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2.
    Tang CT; Li PC; Liu IJ; Liao MY; Chiu CY; Chao DY; Wu HC
    PLoS Negl Trop Dis; 2015; 9(7):e0003903. PubMed ID: 26135599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.